J. Moore

发表

Extramedullary leukemia adversely affects hematologic complete remission rate and overall survival in patients with t(8;21)(q22;q22): results from Cancer and Leukemia Group B 8461.

C. Bloomfield, J. Byrd, M. Qumsiyeh, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II study of weekly intravenous recombinant humanized anti-p185HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer.

D Tripathy, C. Hudis, L. Norton, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

High-dose combination alkylating agents with bone marrow support as initial treatment for metastatic breast cancer.

R. Bast, E. Shpall, J. Gockerman, 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II study of weekly intravenous trastuzumab (Herceptin) in patients with HER2/neu-overexpressing metastatic breast cancer.

C. Hudis, L. Norton, J. Baselga, 1999, Seminars in oncology.

Facilitated light microscopic cytochemical diagnosis of acute myelogenous leukemia.

J. Fay, J. Laszlo, E. Bossen, 1979, Cancer research.

Predictors of outcome of tricuspid valve replacement in carcinoid heart disease.

J. Lowe, T. Bashore, V. Rigolin, 1995, The American journal of cardiology.

Left axis deviation and left anterior hemiblock among 8,000 Japanese-American men.

K. Yano, J. Moore, G. Rhoads, 1975, The American journal of cardiology.

Carcinoid tumors: iodine-131 MIBG scintigraphy.

M. Hanson, R. Coleman, J. Moore, 1989, Radiology.

Improved survival in advanced Hodgkin's disease with the use of combined modality therapy.

E. Winer, D. Brizel, L. Prosnitz, 1990, International journal of radiation oncology, biology, physics.

Arthritis syndromes associated with human T cell lymphotropic virus type I infection.

B. Haynes, D. Patel, J. Moore, 1997, The Medical clinics of North America.

A randomized placebo-controlled trial of recombinant human interleukin-11 in cancer patients with severe thrombocytopenia due to chemotherapy.

G. Rosen, J. Loewy, M. Gordon, 1996, Blood.

Monocytoid differentiation of freshly isolated human myeloid leukemia cells and HL-60 cells induced by the glutamine antagonist acivicin.

J. Weinberg, J. Moore, K. Nichols, 1989, Blood.

Nitric oxide enhancement of fludarabine cytotoxicity for B-CLL lymphocytes

O. Colvin, J. Weinberg, J. Moore, 2001, Leukemia.

CD7+, CD4-, CD8- acute leukemia: a syndrome of malignant pluripotent lymphohematopoietic cells.

T. Waldmann, B. Haynes, S. Bigner, 1989, Blood.

Conversion of a stem cell leukemia from a T-lymphoid to a myeloid phenotype induced by the adenosine deaminase inhibitor 2'-deoxycoformycin.

B. Haynes, J. Whang‐Peng, J. Kurtzberg, 1984, Proceedings of the National Academy of Sciences of the United States of America.

Demonstration of phenotypic abnormalities of thymic epithelium in thymoma including two cases with abundant Langerhans cells.

B. Haynes, V. Kraus, J. Moore, 1988, The American journal of pathology.

Recombinant human erythropoietin therapy for anemic cancer patients receiving cisplatin chemotherapy.

D. S. Gordon, J. Kugler, R. Silver, 1995, The cancer journal from Scientific American.

Detection of both T-cell and Ia-like antigens on cells from patients with acute myelomonocytic leukemia and chronic myelogenous leukemia in blast crisis.

R. Metzgar, J. Moore, J. Anderson, 1979, Cancer research.

The light microscopic demonstration of hydroperoxidase-positive Phi bodies and rods in leukocytes in acute myeloid leukemia

J. Laszlo, J. Moore, J. Hanker, 1978, Histochemistry.

A phase I/II study of galiximab (an anti-CD80 monoclonal antibody) in combination with rituximab for relapsed or refractory, follicular lymphoma.

L. Gordon, M. Czuczman, J. Friedberg, 2007, Annals of oncology : official journal of the European Society for Medical Oncology.

Specific receptors for phorbol diesters on freshly isolated human myeloid and lymphoid leukemia cells: comparable binding characteristics despite different cellular responses.

J. Weinberg, J. Moore, B. Goodwin, 1984, Blood.

Adult patients with de novo acute myeloid leukemia and t(9; 11)(p22; q23) have a superior outcome to patients with other translocations involving band 11q23: a cancer and leukemia group B study.

C. Bloomfield, K. Mrózek, R. Mayer, 1997, Blood.

Evidence for early hematopoietic progenitor cell involvement in acute promyelocytic leukemia.

P. Nowell, M. Wasik, H. Rennert, 1999, American journal of clinical pathology.

Clinical and pharmacologic effects of high dose single agent busulfan with autologous bone marrow support in the treatment of solid tumors.

L. Grochow, R. Bast, H. Seigler, 1987, Cancer research.

Identification of human T cell leukemia virus in a Japanese patient with adult T cell leukemia and cutaneous lymphomatous vasculitis.

B. Haynes, S. E. Miller, R. Metzgar, 1983, Proceedings of the National Academy of Sciences of the United States of America.

I and i antigens on normal and leukemic leukocytes

J. Moore, G. Logue, Gerald L. Logue, 1978, Cancer.

A phase III trial of high-dose cytosine arabinoside with or without etoposide in relapsed and refractory acute myelogenous leukemia. A Southeastern Cancer Study Group trial.

A. Bartolucci, M. Stagg, J. Moore, 1994, Leukemia.

Hepatosplenic T-cell lymphoma: an unusual case of a gamma delta T-cell lymphoma with a blast-like terminal transformation.

M. Borowitz, R. Ware, J. Moore, 1994, Human pathology.

Hodgkin's disease presenting as myelofibrosis

J. Laszlo, J. Moore, R. Kaufman, 1989, Cancer.

Treatment of patients with recurrent gliomas with cyclophosphamide and vincristine.

W. J. Oakes, P. Burger, H. Friedman, 1990, Journal of neurosurgery.

Molecular and cytogenetic characterization of a novel rearrangement involving chromosomes 9, 12, and 17 resulting in ETV6 (TEL) and ABL fusion.

J. Moore, C. Tirado, S. Sebastian, 2005, Cancer genetics and cytogenetics.

Post transplant CD8+ gammadelta T-cell lymphoma associated with human herpes virus-6 infection.

W. Lin, S. T. Traweek, K. Mann, 1999, Leukemia & lymphoma.

Cancer and Leukemia Group B (CALGB) Studies with Hematopoietic Growth Factors in Patients with Acute Myeloid Leukemia

R. Stone, B. Peterson, C. Schiffer, 1994 .

Neural cell adhesion molecule (CD56)-positive acute myelogenous leukemia and myelodysplastic and myeloproliferative syndromes.

S. Bigner, C. Decastro, S. T. Traweek, 1997, American journal of clinical pathology.

Preparation and characterization of lymphocyte-activating factor (LAF) from acute monocytic and myelomonocytic leukemia cells.

R. Metzgar, J. Moore, L. Lachman, 1978, Cellular immunology.

Mitoxantrone in the treatment of relapsed and refractory acute leukemia.

J. Moore, G. Olsen, 1984, Seminars in oncology.

Intensive postremission chemotherapy in adults with acute myeloid leukemia. Cancer and Leukemia Group B.

R. Mayer, C. Schiffer, J. Moore, 1994, The New England journal of medicine.

High frequency of immunophenotype changes in acute myeloid leukemia at relapse: implications for residual disease detection (Cancer and Leukemia Group B Study 8361).

C. Bloomfield, C. Schiffer, R. Larson, 2001, Blood.

Patients with t(8;21)(q22;q22) and acute myeloid leukemia have superior failure-free and overall survival when repetitive cycles of high-dose cytarabine are administered.

C. Bloomfield, J. Byrd, M. Qumsiyeh, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Hematologic engraftment and reconstitution of immune function post unrelated placental cord blood transplant in an adult with acute lymphocytic leukemia.

J. Kurtzberg, D. Rizzieri, P. Rubinstein, 1998, Leukemia research.

Comparison of the efficacy of a two-day and a five-day schedule for infusing intravenous gamma globulin in the treatment of immune thrombocytopenic purpura in adults.

R. Coleman, J. Moore, W. Rosse, 1987, The American journal of medicine.

Fumagillin analog in the treatment of Kaposi's sarcoma: a phase I AIDS Clinical Trial Group study. AIDS Clinical Trial Group No. 215 Team.

J. V. Von Roenn, J. Holden-Wiltse, S. Shriver, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Postremission therapy in older patients with de novo acute myeloid leukemia: a randomized trial comparing mitoxantrone and intermediate-dose cytarabine with standard-dose cytarabine.

Edward J. Lee, C. Bloomfield, S. George, 2001, Blood.

Escalation of daunorubicin and addition of etoposide in the ADE regimen in acute myeloid leukemia patients aged 60 years and older: Cancer and Leukemia Group B Study 9720

R M Stone, S L George, M. Caligiuri, 2011, Leukemia.

Leukopheresis therapy of leukemic reticuloendotheliosis (hairy cell leukemia).

J. Fay, A. Huang, J. Moore, 1979, Blood.

Randomized multicenter trial of cytosine arabinoside with mitoxantrone or daunorubicin in previously untreated adult patients with acute nonlymphocytic leukemia (ANLL). Lederle Cooperative Group.

P. Desai, E. Feldman, J. Moore, 1990, Leukemia.

Open-label randomized clinical trial of standard neoadjuvant chemotherapy with paclitaxel followed by FEC versus the combination of paclitaxel and everolimus followed by FEC in women with triple receptor-negative breast cancer†.

G. Mills, G. Hortobagyi, L. Pusztai, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

Cigarette smoking and risk of acute leukemia: associations with morphology and cytogenetic abnormalities in bone marrow.

C. Schiffer, R. Mayer, R. Silver, 1993, Journal of the National Cancer Institute.

Phase I/II study of the P-glycoprotein modulator PSC 833 in patients with acute myeloid leukemia.

T. Grogan, W. Dalton, R. Dorr, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Chronic lymphocytic leukemia and regulatory B cells share IL-10 competence and immunosuppressive function

T. Tedder, G. Venturi, T. Matsushita, 2013, Leukemia.

LMP-420: a novel purine nucleoside analog with potent cytotoxic effects for CLL cells and minimal toxicity for normal hematopoietic cells

S. Pizzo, J. Gockerman, D. Friedman, 2010, Leukemia.

Granulocyte-colony stimulating factor (filgrastim) accelerates granulocyte recovery after intensive postremission chemotherapy for acute myeloid leukemia with aziridinyl benzoquinone and mitoxantrone: Cancer and Leukemia Group B study 9022.

Edward J. Lee, R. Dodge, J. Kolitz, 1997, Blood.

Randomized, multicenter, open-label study of pegfilgrastim compared with daily filgrastim after chemotherapy for lymphoma.

J. Vose, I. Flinn, D. Schenkein, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Cytogenetic and molecular analysis of an unusual case of acute promyelocytic leukemia with a t(15;17;17)(q22;q23;q21).

J. Moore, P. Buckley, C. Tirado, 2003, Cancer genetics and cytogenetics.

Granulocyte-macrophage colony-stimulating factor after initial chemotherapy for elderly patients with primary acute myelogenous leukemia. Cancer and Leukemia Group B.

S. George, R. Dodge, R. Stone, 1995, The New England journal of medicine.

Apolipoprotein E genotype as a determinant of survival in chronic lymphocytic leukemia

W. Strittmatter, D. Rizzieri, N. Jiang, 2008, Leukemia.

Phase II trial of lymphoblastoid interferon in metastatic colon carcinoma.

J. Laszlo, J. Moore, P. Silverman, 1983, Cancer treatment reports.

A phase I/II study of combined cisplatin and hyperthermia treatment for refractory malignancy.

J. Oleson, D. Green, G. Burton, 1987, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

Autologous marrow transplantation for patients with acute myelogenous leukemia--a preliminary report.

J. Fay, A. Huang, K. Noell, 1979, Experimental hematology.

Clinicopathologic and cytogenic features of CD34 (My 10)-positive acute nonlymphocytic leukemia.

S. Bigner, M. Borowitz, C. Civin, 1989, American journal of clinical pathology.

Follicular mucinosis as a presenting sign of acute myeloblastic leukemia.

J. Grichnik, C. Shea, J. Moore, 1998, Journal of the American Academy of Dermatology.

Nitric oxide modulation of the growth and differentiation of freshly isolated acute non-lymphocytic leukemia cells.

J. Gockerman, J. Weinberg, J. Moore, 1995, Leukemia research.

Intraluminal thrombus and bowel obstruction in acute leukemia due to bleeding Meckel's diverticulum.

M. Neuss, J. Moore, G. Leight, 1986, The American journal of medicine.

Long-term follow-up of a randomized post-induction therapy trial in acute myelogenous leukemia (a Southeastern Cancer Study Group trial).

A. Bartolucci, M. Stagg, J. Moore, 1995, Leukemia.

Estrogen receptor determination in percutaneous bone marrow biopsies of patients with metastatic breast cancer.

K. Mccarty, J. Moore, R. Rundles, 1979, Medical and pediatric oncology.

Core binding factor acute myeloid leukemia. Cancer and Leukemia Group B (CALGB) Study 8461.

C. Bloomfield, J. Byrd, R. Larson, 2004, Annals of hematology.

Leukemia-associated arthritis: identification of leukemic cells in synovial fluid using monoclonal and polyclonal antibodies.

B. Haynes, J. Moore, E. Harden, 1984, Arthritis and rheumatism.

Craniocerebral plasmacytoma: MR features.

R. McLendon, A. Friedman, J. Provenzale, 1997, AJNR. American journal of neuroradiology.

The usefulness of CD64, other monocyte-associated antigens, and CD45 gating in the subclassification of acute myeloid leukemias with monocytic differentiation.

A. Krasinskas, M. Wasik, M. Kamoun, 1998, American journal of clinical pathology.

Metastatic breast cancer: understanding current management options.

K. McGinn, J. Moore, 2001, Oncology nursing forum.

Detection and Partial Characterization of Human Thymus-Leukemia Antigens

R. Metzgar, J. Moore, J. Falletta, 1980 .